BioLife Solutions Named one of the Fastest Growing Companies in North America on Deloitte’s 2019 Technology Fast 500™
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of a portfolio of best-in-class bioproduction tools for cell and gene therapies, recently announced that based on revenue growth from 2015 to 2018, it has been selected for inclusion on the Deloitte 2019 Technology Fast 500 list. Mike Rice, BioLife President and CEO, commented, “We […]
BioLife Solutions to Acquire SAVSU Technologies
We’re Joining Forces! BioLife Solutions announces intent to purchase SAVSU Technologies shares outstanding. On July 8, 2019, BioLife issued a press release announcing that the company will purchase the remaining 56% of shares of SAVSU that BioLife does not presently own. The acquisition is expected to close within 45 days. BioLife’s relationship with SAVSU spans six years, during the development and […]
The Benefits of Biobanking
Biobanking is a fascinating sector of the biological pharmaceutical industry. Biobanking is the process of collecting samples of bodily fluid (blood, urine, etc) or tissue for the purpose of research. The research done on these bio samples helps improve our understanding of health and disease. Traditionally, information such as height, weight, and other health bearing questions will […]
Understanding Temperature Ranges In Biological Storage
Storage conditions for pharmaceuticals and biological materials must adhere to precise regulations in order to protect these products and ensure their quality remains consistent. But you may not realize that there are several different temperature ranges used in biostorage — each with its own specific conditions and considerations. In today’s post, we’ll examine the options your cold […]
SAVSU Joins Forces with BioLife Solutions
BioLife Solutions issued a press release August 8, 2019, announcing the execution of a share exchange agreement to purchase the remaining 56% of shares of SAVSU Technologies that BioLife did not previously own. BioLife’s relationship with Savsu spans six years, during the development and growth of the evo® Cold Chain 2.0™ system, encompassing evo® hardware and evo.is® software®. Since January 2019, Savsu […]
Understanding the Importance of Temperature Control in Pharmaceutical Stability
If you regularly work with pharmaceuticals, you’ll already understand the importance of dispensing those drugs properly. An error during this stage could have a significant impact on consumer safety and well-being. The same can be said of errors made during the storage phase. Pharmaceutical storage plays a vital role in drug safety. Therefore, adequate storage […]
TrakCel and Quick Life Science Group Announce Partnership
According to data provided by the Alliance for Regenerative Medicine, there are nearly 900 companies responsible for more than 1000 industry-sponsored clinical trials within regenerative medicine utilizing advanced therapeutics including cell, gene, and tissue engineered products. Maintaining oversight on these precious therapies, literally vein-to-vein, encompassing a multitude of stakeholders, lengthy timelines, across countries and continents is […]
BioPreservation Article Update 12/20/18
One of the benefits of cryopreserving cells is the flexibility in scheduling for later use that freezing provides. Determining the optimal solution for cryopreservation that consistently results in post-thaw recovery of the greatest number of highly viable, functional cells is crucial. The article by Sara S. Parker et al. published in eNeuro and recently added to BioLife’s Evidence […]
Kolon TissueGene Doses First Patient in U.S. Phase III Clinical Trial
On November 21, 2018, BioLife’s customer Kolon TissueGene, Inc., a leader in advanced cell and gene therapies, announced that it has dosed its first patient in its pivotal US Phase III clinical trials for Invossa, a cell and gene therapy in development for knee osteoarthritis (OA). “This is an exciting step for Kolon TissueGene as we […]
Journal Articles Citing Cryopreservation Component Recently Added to BioLife Solutions’ Evidence Library
Cryopreservation adds flexibility to timelines when working with cells. In the case of cellular therapies, that can mean initial flexibility to schedule patient cell collection, transport cells to the manufacturing facility and initiate manufacturing. Cryopreservation of the final cell therapy product adds flexibility to be able to schedule the return of cells to the patient care […]